Literature DB >> 17488905

Antibody recognition of heterologous variant surface antigens after a single Plasmodium falciparum infection in previously naive adults.

Salenna R Elliott1, Paul D Payne, Michael F Duffy, Timothy J Byrne, Wai-Hong Tham, Stephen J Rogerson, Graham V Brown, Damon P Eisen.   

Abstract

Antibodies to variant surface antigens (VSA) including Plasmodium falciparum erythrocyte membrane protein 1 (PfEMP1) have been associated with protective antimalarial immunity that appears to be variant-specific. This study of adult returned travelers with a single acute P. falciparum infection investigated whether a primary antibody response includes IgG specific for heterologous VSA. We found that 11 of 14 patients had IgG reactive with up to six P. falciparum lines expressing different heterologous PfEMP1 variants, measured by flow cytometry (reactivity greater than two times the mean of the negative control sera was defined as "positive"), with high reactivity (greater than four times the mean of the negative controls) detected in three patients. The dominant variant(s) recognized differed between seropositive individuals. Despite previous evidence that antibody responses to heterologous VSA are short-lived, seven patients had detectable IgG at > 20 weeks post-infection. Together these data suggest that a single P. falciparum infection can be sufficient to induce antibodies reactive with several PfEMP1 variants, although the repertoire of target epitopes they recognize may still be restricted.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17488905

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  20 in total

1.  Evaluation of the antigenic diversity of placenta-binding Plasmodium falciparum variants and the antibody repertoire among pregnant women.

Authors:  Mirja Hommel; Salenna R Elliott; Viju Soma; Greg Kelly; Freya J I Fowkes; Joanne M Chesson; Michael F Duffy; Joseph Bockhorst; Marion Avril; Ivo Mueller; Andrew Raiko; Danielle I Stanisic; Stephen J Rogerson; Joseph D Smith; James G Beeson
Journal:  Infect Immun       Date:  2010-02-16       Impact factor: 3.441

Review 2.  Imported Malaria in Countries where Malaria Is Not Endemic: a Comparison of Semi-immune and Nonimmune Travelers.

Authors:  Johannes Mischlinger; Caroline Rönnberg; Míriam J Álvarez-Martínez; Silja Bühler; Małgorzata Paul; Patricia Schlagenhauf; Eskild Petersen; Michael Ramharter
Journal:  Clin Microbiol Rev       Date:  2020-03-11       Impact factor: 26.132

3.  How selection forces dictate the variant surface antigens used by malaria parasites.

Authors:  Maite Severins; Don Klinkenberg; Hans Heesterbeek
Journal:  J R Soc Interface       Date:  2011-07-06       Impact factor: 4.118

4.  Identification of VAR2CSA domain-specific inhibitory antibodies of the Plasmodium falciparum erythrocyte membrane protein 1 using a novel flow cytometry assay.

Authors:  Harold Obiakor; Marion Avril; Nicholas J Macdonald; Prakash Srinivasan; Karine Reiter; Charles Anderson; Kevin L Holmes; Michal Fried; Patrick E Duffy; Joseph D Smith; David L Narum; Louis H Miller
Journal:  Clin Vaccine Immunol       Date:  2013-01-23

5.  An assay to probe Plasmodium falciparum growth, transmission stage formation and early gametocyte development.

Authors:  Nicolas M B Brancucci; Ilana Goldowitz; Kathrin Buchholz; Kristine Werling; Matthias Marti
Journal:  Nat Protoc       Date:  2015-07-02       Impact factor: 13.491

6.  Immunization with VAR2CSA-DBL5 recombinant protein elicits broadly cross-reactive antibodies to placental Plasmodium falciparum-infected erythrocytes.

Authors:  Marion Avril; Megan M Cartwright; Marianne J Hathaway; Mirja Hommel; Salenna R Elliott; Kathryn Williamson; David L Narum; Patrick E Duffy; Michal Fried; James G Beeson; Joseph D Smith
Journal:  Infect Immun       Date:  2010-03-01       Impact factor: 3.441

7.  Characterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers.

Authors:  Darren R Krause; Michelle L Gatton; Sarah Frankland; Damon P Eisen; Michael F Good; Leann Tilley; Qin Cheng
Journal:  Infect Immun       Date:  2007-10-08       Impact factor: 3.441

Review 8.  Acquired immunity to malaria.

Authors:  Denise L Doolan; Carlota Dobaño; J Kevin Baird
Journal:  Clin Microbiol Rev       Date:  2009-01       Impact factor: 26.132

9.  Naturally acquired immunity against immature Plasmodium falciparum gametocytes.

Authors:  Kathleen W Dantzler; Siyuan Ma; Priscilla Ngotho; Will J R Stone; Dingyin Tao; Sanna Rijpma; Mariana De Niz; Sandra K Nilsson Bark; Matthijs M Jore; Tonke K Raaijmakers; Angela M Early; Ceereena Ubaida-Mohien; Leandro Lemgruber; Joseph J Campo; Andy A Teng; Timothy Q Le; Cassidy L Walker; Patricia Hermand; Philippe Deterre; D Huw Davies; Phil Felgner; Isabelle Morlais; Dyann F Wirth; Daniel E Neafsey; Rhoel R Dinglasan; Miriam Laufer; Curtis Huttenhower; Karl Seydel; Terrie Taylor; Teun Bousema; Matthias Marti
Journal:  Sci Transl Med       Date:  2019-06-05       Impact factor: 17.956

10.  Cytokine and antibody responses to Plasmodium falciparum in naïve individuals during a first malaria episode: effect of age and malaria exposure.

Authors:  Gemma Moncunill; Alfredo Mayor; Alfons Jiménez; Augusto Nhabomba; Laura Puyol; Maria N Manaca; Diana Barrios; Pau Cisteró; Caterina Guinovart; Ruth Aguilar; Azucena Bardají; María-Jesús Pinazo; Evelina Angov; Sheetij Dutta; Chetan E Chitnis; José Muñoz; Joaquim Gascón; Carlota Dobaño
Journal:  PLoS One       Date:  2013-02-21       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.